During a live event, Matthew Lunning, DO, and participants discussed the process of determining if patients with DLBCL should ...

Covenant Health has announced the launch of CAR T-cell therapy at the Joe Arrington Cancer Research & Treatment Center (JACC) ...

T cells and/or bispecific antibody (BsAb) has been established and become a promising treatment strategy for relapsed/refractory B-cell lymphomas. To further improve their therapeutic efficacy, ...

Dr. Olalekan O. Oluwole, discusses treating patients from underserved communities with CAR T-cell therapy, as well as ...

During a live event, Jorge Monge, MD, discussed real-world evidence on the use of CAR T-cell therapy beyond the trial setting ...

Jaipur: SMS Hospital has established a department for treatment of blood-related cancers and other blood disorders. The ...

Join Drs Amelia Langston and Jonathan L. Kaufman, MD, as they discuss current CAR–T cell for B-cell lymphomas as leading researchers and practitioners in the field.

Dr. John Mellors, who heads the cell therapy discovery team for biotechnology company Galapagos, talks about the innovations the organization is making to improve delivery speed and access to CAR ...

CAR T-cell therapy is a unique way of treating hematologic malignancies, such as leukemia and lymphoma, where doctors will harness and use your own cells in order to effectively eradicate the cancer, ...

This next-generation CAR T-cell therapy has already been tested in preclinical models of HER2-positive breast cancer derived from patients who have shown a complete, durable, and safe antitumor ...

Janssen’s drug JNJ-68284528 is currently being evaluated for the treatment of CAR T-Cell Therapy for Multiple Myeloma. The ...

In the third patient, all cutaneous manifestations, including facial rash and discoid lesions, improved after CAR T-cell therapy, along with a reduction in proteinuria from 7 g to 2.4 g at day 70 ...